Joint Formulary & PAD

Rotigotine - Parkinson's disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Patches
Associated Icons :
Restrictions / Comments :
Important
Consider patches if levodopa and / or oral dopamine are not effective in treating nocturnal akinesia

Documentation

PAD Profile

ChemicalSubstance :
Rotigotine
Indication :
Parkinson's disease
Group Name :
Keywords :
PD, nocturnal akinesia, Parkinsons patch
Brand Names Include :
Neupro
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Rotigotine is used to treat.

Committee Recommendations (1)

Rotigotine patches may be considered if levodopa and / or oral dopamine agonists are not effective in treating nocturnal akinesia